Palate transmembrane 1-like (CLPTM1L), also called cisplatin resistance related gene 9 (CRR9), was identified among the genes involved in resistance to the anticancer drug cisplatin in ovarian cancer cells [1]. Here, CLPTM1L is linked to ovarian cancer.